Corporate report: MHRA-NICE Real-World Evidence Scientific Dialogue
Key Changes
- Described as MHRA-NICE Real-World Evidence Scientific Dialogue programme
- Stated to help decision making across the lifecycle of products
- Stated to benefit both regulatory and health technology assessment (HTA) evaluations
Affected Roles
Regulatory AffairsHealth Technology Assessment (HTA)
Action Required
Original source must be reviewed before compliance decisions; suggest reviewing the programme description to assess potential relevance for regulatory and HTA evidence planning.